Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Go

Showing results (131-140 of 571) with videos related to

Pageof 58
Sort By:
Pediatrics|August 14, 2020
Community-Based Epidemiology of Hospitalized Acute Kidney InjuryRishi V Parikh, Thida C Tan, Anne S Salyer, et al.
Journal of the American College of Cardiology|July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Geriatrics Society|November 19, 2016
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation StudyJeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Annals of Internal Medicine|November 17, 2004
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillationMargaret C Fang, Yuchiao Chang, Elaine M Hylek, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA studyDaniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
The American Journal of Cardiology|March 26, 2016
Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal DiseaseAshok Krishnaswami, Anne C H Goh, Alan S Go, et al.
Plos One|November 1, 2023
CKD stage-specific utility of two equations for predicting 1-year risk of ESKDSijie Zheng, Rishi V Parikh, Thida C Tan, et al.
Circulation. Cardiovascular Quality and Outcomes|October 21, 2010
Warfarin discontinuation after starting warfarin for atrial fibrillationMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
The American Journal of Cardiology|July 9, 2014
Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarinGene R Quinn, Daniel E Singer, Yuchiao Chang, et al.
Neurology|February 18, 2014
Long-term survival after ischemic stroke in patients with atrial fibrillationMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Pageof 58

Showing results (131-140 of 571) with videos related to

Sort By:
Pageof 58
Pediatrics|August 14, 2020
Community-Based Epidemiology of Hospitalized Acute Kidney InjuryRishi V Parikh, Thida C Tan, Anne S Salyer, et al.
Journal of the American College of Cardiology|July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Geriatrics Society|November 19, 2016
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation StudyJeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Annals of Internal Medicine|November 17, 2004
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillationMargaret C Fang, Yuchiao Chang, Elaine M Hylek, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA studyDaniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
The American Journal of Cardiology|March 26, 2016
Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal DiseaseAshok Krishnaswami, Anne C H Goh, Alan S Go, et al.
Plos One|November 1, 2023
CKD stage-specific utility of two equations for predicting 1-year risk of ESKDSijie Zheng, Rishi V Parikh, Thida C Tan, et al.
Circulation. Cardiovascular Quality and Outcomes|October 21, 2010
Warfarin discontinuation after starting warfarin for atrial fibrillationMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
The American Journal of Cardiology|July 9, 2014
Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarinGene R Quinn, Daniel E Singer, Yuchiao Chang, et al.
Neurology|February 18, 2014
Long-term survival after ischemic stroke in patients with atrial fibrillationMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Pageof 58